3 completed. 2 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Phase 4 | 1 | Completed 1 |
Follow leukocyte endogenous mediator: new trials by email Literature Review of leukocyte endogenous mediator trials Research Report on leukocyte endogenous mediator
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Transitioning to Lemborexant in Japanese Subjects With Insomnia Lemborexant (LEM) 5 mg (Z-Drug-mono cohort), Lemborexant (LEM) 5 mg (SUV-mono cohort), Lemborexant (LEM) 5 mg (SUV-combination cohort) - Insomnia | Phase 4 | Completed | Kurume University | 97 | 2021-03-24 | 2023-03-15 |
| A Study to Evaluate Next-Dose Transition From Zolpidem to Lemborexant (LEM) for the Treatment of Insomnia LEM 5 mg, LEM 10 mg - Insomnia | Phase 3 | Completed | Eisai Inc. | 53 | 2019-07-15 | 2021-04-12 |
| Transarterial Ethanol Ablation (TEA) Versus Transcatheter Arterial Chemoembolisation (TACE) for Hepatocellular Carcinoma TEA with LEM, TACE - Hepatocellular Carcinoma | Phase 3 | Completed | Chinese University of Hong Kong | 98 | 2007-06-01 | 2015-01-26 |
Sleep Initiation and Maintenance Disorders (2) · Carcinoma, Hepatocellular (1)
Chinese University of Hong Kong (1) · Eisai Inc. (1) · Kurume University (1)
Hong Kong (1) · Japan (1) · United States (1)
Motohiro Ozone (1) · Simon CH Yu, MD, FRCR (1)